On May 18, shares in the First Capital Inc. company were selling at $24.25.
First Capital Inc. employs 184 people and has reported $13,190,000 in income as of May 18.
In the fluctuating stock market, healthcare and technology stocks are viewed as the safest bets for long-term gains.
Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, meaning they’re a stable investment.
While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.
For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
| Company Name | % of Change in Last Year | Selling Price |
|---|---|---|
| Bravo Multinational Inc. | 1,448.71% | $0.4801 |
| Digital Brand Media & Marketing Group Inc. | 966.67% | $0.0064 |
| Bellerophon Therapeutics Inc. | 792.45% | $9.46 |
| Ameritek Ventures Inc | 740% | $0.0126 |
| Cabaletta Bio Inc. | 654.6% | $12.3 |
| Biomea Fusion Inc. | 519.08% | $32.13 |
| Arcellx Inc | 471.43% | $41.2 |
| 89Bio Inc. | 471.28% | $16.91 |
| Ardelyx Inc. | 453.36% | $3.64 |
| Akero Therapeutics Inc. | 421.74% | $45.6 |
| Atlas Lithium Corp | 409.09% | $21 |
| Eline Entertainment Group Inc | 400% | $0.0005 |
| Cymabay Therapeutics Inc. | 376.32% | $9.05 |
| Clearone Inc. | 340.14% | $2.43 |
| Elf Beauty Inc. | 319.1% | $90.61 |
| Enliven Therapeutics Inc | 311.07% | $20.06 |
| Blue Dolphin Energy Co. | 309.63% | $3.2 |
| Aehr Test Systems | 293.22% | $31.89 |
| Aldeyra Therapeutics Inc. | 292.28% | $9.65 |
| Aldeyra Therapeutics Inc. | 292.28% | $9.65 |
| Findit Inc. | 289.29% | $0.0545 |
| Harrow Health Inc. | 263.08% | $20.95 |
| Bird Global Inc. | 258.24% | $2.8 |
| Akebia Therapeutics Inc | 225.96% | $1.09 |
| GlycoMimetics Inc. | 225.29% | $1.96 |
| Astria Therapeutics Inc. | 219.85% | $12.57 |
| Amylyx Pharmaceuticals Inc | 207.21% | $26.85 |
| Corvus Pharmaceuticals Inc. | 206.6% | $3.25 |
| Cannabis Suisse Corp. | 202.4% | $0.0629 |
| Hims & Hers Health Inc. | 201.17% | $10.27 |
| Accustem Sciences Ltd | 198.25% | $1.7 |
| Apptech Corp. | 197.67% | $1.9 |
| Muscle Maker Inc. | 196.1% | $1.14 |
| Freedom Holdings Inc. | 191.35% | $0.1751 |
| Applied Digital Corp | 190.94% | $7.39 |
| Fluence Energy Inc. | 177.16% | $22.45 |
| Bel Fuse Inc. | 176.93% | $45.5 |
| Bel Fuse Inc. | 176.93% | $45.5 |
| EMagin Corp. | 175.34% | $2.01 |
| Cidara Therapeutics Inc | 174.83% | $1.27 |
| Array Technologies Inc. | 170.12% | $22.96 |
| Burzynski Research Institute Inc. | 170% | $0.0405 |
| Heritage Global Inc. | 168.91% | $3.2 |
| Cogent Biosciences Inc. | 158.51% | $10.78 |
| BrightRock Gold Corp. | 156.42% | $0.3837 |
| Axcelis Technologies Inc. | 153.45% | $144.52 |
| Vita Coco Company Inc. | 153.15% | $24.48 |
| CVRx Inc. | 149.9% | $12.62 |
| Cadiz Inc. | 148.44% | $4.77 |
| Axsome Therapeutics Inc. | 146.93% | $76.87 |